Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2923
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00651508 | Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT07725497 | A Study of Luspatercept in People With Anemia | ||
| NCT02533960 | Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime | ||
| NCT03728361 | Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer | ||
| NCT03335553 | A Study of Experimental Medication BMS-986235 in Healthy Subjects | ||
| NCT03273790 | A Retrospective Study of the Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in Japan | ||
| NCT03557359 | Nivolumab for Recurrent or Progressive IDH Mutant Gliomas | ||
| NCT01709162 | Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma | ||
| NCT00002041 | Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients | ||
| NCT00664625 | A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects | ||
| NCT06121843 | A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma | ||
| NCT05375643 | SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention) | ||
| NCT03192215 | AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke | ||
| NCT00122603 | Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127) | ||
| NCT03661320 | A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer | ||
| NCT05638282 | A Study to Evaluate the Safety and Tolerability of Cendakimab in Chinese Healthy Participants | ||
| NCT01995266 | Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual | ||
| NCT02107755 | Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma | ||
| NCT03405155 | Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery | ||
| NCT04810078 | A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread | ||
| NCT00382460 | Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22) | ||
| NCT01097642 | Neo-Adjuvant Study in Triple Negative Breast Cancer Patients | ||
| NCT04389541 | Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology | ||
| NCT06882785 | A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia | ||
| NCT01721759 | Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens | ||
| NCT01240980 | Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B) | ||
| NCT00364286 | Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825) | ||
| NCT07101094 | Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU) | ||
| NCT03843515 | Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction | ||
| NCT02213068 | Belatacept 3 Month Post Transplant Conversion Study | ||
| NCT01055691 | A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets | ||
| NCT02671461 | Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes" | ||
| NCT06672523 | A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion | ||
| NCT03634969 | An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants | ||
| NCT03451331 | Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer | ||
| NCT01454102 | Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012) | ||
| NCT07526961 | Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland | ||
| NCT03226756 | Nivolumab in Recurrent and/or Metastatic SCCHN | ||
| NCT02095860 | Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325 | ||
| NCT05432622 | A Study of Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy | ||
| NCT04965402 | A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986166 in Healthy Japanese Participants | ||
| NCT01965639 | Southeastern Diabetes Initiative Clinical Intervention | ||
| NCT00483405 | Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer | ||
| NCT01235351 | Escalating Clopidogrel by Involving a Genetic Strategy - Thrombolysis In Myocardial Infarction 56 | ||
| NCT01155427 | Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB) | ||
| NCT04717154 | Ipilimumab With Nivolumab for Molecular-selected Patients With Castration-resistant Prostate Cancer | ||
| NCT02598960 | An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread. | ||
| NCT00162227 | An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection | ||
| NCT04141254 | Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism. | ||
| NCT05005273 | A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer |
